Pico-C Reveals Early Genome 3D Structure
Analysis based on 7 articles · First reported Feb 24, 2026 · Last updated Feb 27, 2026
This medical breakthrough, particularly the development of Pico-C technology, could significantly impact the biotechnology and pharmaceutical industries by enabling more detailed study of gene regulation and disease mechanisms. While not directly affecting stock prices immediately, it lays groundwork for future drug discovery and therapeutic interventions.
Scientists led by Professor Juanma Vaquerizas at Imperial College London and the MRC Laboratory of Medical Sciences have overturned a long-standing assumption about genome organization in newly fertilized eggs. They developed a breakthrough technology called Pico-C, which allows for unprecedented detailed visualization of the 3D genome structure. Their research, published in Nature Genetics, reveals that a sophisticated 3D scaffold of DNA is already being built before Zygotic Genome Activation, challenging the previous 'blank slate' view. A companion study, led by Professor Ulrike Kutay at ETH Zurich and published in Nature Cell Biology, applied this high-resolution mapping to human cells, demonstrating that the collapse of this 3D structure can trigger a false viral attack alarm, leading to inflammation and disease. These findings, funded by the United Kingdom===Medical Research Council and the Academy of Medical Sciences (United Kingdom), are crucial for understanding developmental defects and diseases.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard